Inhaled treatment of COPD: a Delphi consensus statement (Q42227819)

19 October 2017

Inhaled treatment of COPD: a Delphi consensus statement (English)

1 reference

19 October 2017

Vincent Ninane

1

1 reference

19 October 2017

Jean-Louis Corhay

2

1 reference

19 October 2017

Paul Germonpré

3

1 reference

19 October 2017

Wim Janssens

4

1 reference

19 October 2017

Guy F Joos

5

1 reference

19 October 2017

Giuseppe Liistro

6

1 reference

19 October 2017

Walter Vincken

7

1 reference

19 October 2017

Sandra Gurdain

8

1 reference

19 October 2017

Evelyne Vanvlasselaer

9

1 reference

19 October 2017

An Lehouck

10

1 reference

19 October 2017

language of work or name

English

0 references

publication date

6 March 2017

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

19 October 2017

1 reference

19 October 2017

12

1 reference

19 October 2017

793-801

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

19 October 2017

start time

1 March 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Inhaled corticosteroids in COPD: the clinical evidence

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Tiotropium for stable chronic obstructive pulmonary disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Research guidelines for the Delphi survey technique.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

How far is real life from COPD therapy guidelines? An Italian observational study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification

30 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5345984

Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease Guidelines for Predicting Mortality and Hospitalization

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28293106

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28293106

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Consensus methods: characteristics and guidelines for use

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28293106

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/COPD.S125564

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

28293106

1 reference